On Saturday, the seventh-seeded Indian duo was defeated by South Korea's Kim Won-ho and Seo Seung-Jae 10-21, 15-21 in a rather one-sided match within 40 minutes, bringing an end to the Indian ...

Satwiksairaj Rankireddy and Chirag Shetty find themselves in a flux that’s occurred but never quite made headlines: missing making finals at All England, World Championship and the ultimate coup de ...

India's challenge at the Malaysia Open 2025 came to an end on Saturday, January 11 as Satwiksairaj Ranbkireddy and Chirag Shetty crashed out of the competition in the semi-finals of the men's doubles.

Here are all the updates from January 11, 2025. Badminton: A big one as Satwiksairaj Rankireddy and Chirag look to reach the final of the season-opening Malaysia Open Super 1000. Their men's ...

Indian badminton stars Satwiksairaj Rankireddy and Chirag Shetty continued their stellar run on the international stage by reaching the men’s doubles semifinals of the prestigious Malaysia Open Super ...

Royalty Pharma (RPRX) announced two major steps to enhance shareholder value. First, the Board of Directors has agreed to acquire its external manager, RP Management. This transaction to simplify ...

Top male singles player H.S Prannoy, doubles specialists Satwiksairaj Rankireddy/Chirag Shetty, women’s singles star Malvika Bansod, mixed doubles pair Dhruv Kapila/Tanisha Crasto and Sathish ...

Amy also shares the importance of getting to know the individuals behind the big Pharma logos, which helps patients to believe that these organisations “have a heart”. To listen to this ...

India has been traditionally quite strong in the pharma sector, with a low cost of manufacturing (30%–35% lower than in the US and Europe), cost-efficient R&D (about 87% less than in developed markets ...

(Image Credits: Pixabay) Amid the growing burden of non-communicable diseases and ageing population, the pharmaceutical sector has thrived tremendously over the recent years. Industry leaders ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds across Big Pharma skyrocketed by 281%. In 2024, Fierce Biotech reported 192 ...

Novo Nordisk, for its part, is expected to jump from 10th place to sixth this year, according to Evaluate Pharma’s consensus forecasts. Nevertheless, it’s Roche that’s been tipped to stand ...